Free Trial
Fall Lock-In Sale! MarketBeat All Access, $149 a Year for Life
Lock In $149
Claim MarketBeat All Access Sale Promotion

LifeStance Health Group (LFST) Stock Price, News & Analysis

LifeStance Health Group logo
$12.93 +0.37 (+2.95%)
Closing price 10/23/2026 04:00 PM Eastern
Extended Trading
$12.82 -0.12 (-0.89%)
As of 10/23/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About LifeStance Health Group Stock (NASDAQ:LFST)

Advanced

Key Stats

Today's Range
$12.42
▼
$12.95
50-Day Range
$11.74
▼
$13.38
52-Week Range
$4.77
▼
$13.56
Volume
2.98 million shs
Average Volume
3.29 million shs
Market Capitalization
$4.94 billion
P/E Ratio
99.47
Dividend Yield
N/A
Price Target
$13.13
Consensus Rating
Moderate Buy

Company Overview

LifeStance Health Group, Inc. is a provider of outpatient behavioral health services in the United States. Through a network of clinicians and care centers, the company offers mental health care through in-person appointments and telehealth visits.

LifeStance’s services include individual, couples and family therapy; psychiatric evaluation and medication management; psychological and neuropsychological testing; and treatment for conditions such as depression, anxiety, attention-deficit/hyperactivity disorder, bipolar disorder, post-traumatic stress disorder and other behavioral health concerns. Its clinicians include psychiatrists, psychologists, therapists and psychiatric nurse practitioners.

Founded in 2017, LifeStance serves patients across multiple states through an integrated platform intended to make behavioral health care more accessible and coordinated. The company completed its initial public offering on the Nasdaq in 2021 under the symbol LFST.

AI Generated. May Contain Errors.

LifeStance Health Group Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
73rd Percentile Overall Score

LFST MarketRank™: 
3.63727858293 of 5 stars

LifeStance Health Group scored higher than 73% of companies evaluated by MarketBeat, and ranked 172nd out of 905 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    LifeStance Health Group has received a consensus rating of Moderate Buy. The company's average rating score is 2.73, and is based on 1 strong buy rating, 6 buy ratings, 4 hold ratings, and no sell ratings.

  • Upside/Downside

    The consensus price target for LifeStance Health Group is close to its current price, suggesting limited near-term upside or downside.

  • Amount of Analyst Coverage

    LifeStance Health Group has been the subject of 6 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about LifeStance Health Group's stock forecast and price target.
  • Earnings Growth

    Earnings for LifeStance Health Group are expected to grow by 43.75% in the coming year, from $0.16 to $0.23 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of LifeStance Health Group is 99.47, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 44.39.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of LifeStance Health Group is 99.47, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 271.33.

  • Price to Book Value per Share Ratio

    LifeStance Health Group has a P/B Ratio of 3.31. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about LifeStance Health Group's valuation and earnings.
  • Percentage of Shares Shorted

    4.21% of the float of LifeStance Health Group has been sold short.
  • Short Interest Ratio / Days to Cover

    LifeStance Health Group has a short interest ratio ("days to cover") of 2.55, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in LifeStance Health Group has recently decreased by 4.62%, indicating that investor sentiment is improving.
  • Dividend Yield

    LifeStance Health Group does not currently pay a dividend.

  • Dividend Growth

    LifeStance Health Group does not have a long track record of dividend growth.

  • News Sentiment

    LifeStance Health Group has a news sentiment score of 1.76. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.46 average news sentiment score of Healthcare companies.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for LifeStance Health Group this week, compared to 3 articles on an average week.
  • Search Interest

    Only 1 people have searched for LFST on MarketBeat in the last 30 days. This is a decrease of -75% compared to the previous 30 days.
  • MarketBeat Follows

    2 people have added LifeStance Health Group to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, LifeStance Health Group insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $146,433,781.00 in company stock.

  • Percentage Held by Insiders

    3.50% of the stock of LifeStance Health Group is held by insiders.

  • Percentage Held by Institutions

    85.50% of the stock of LifeStance Health Group is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about LifeStance Health Group's insider trading history.
Receive LFST Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for LifeStance Health Group and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

LFST Stock News Headlines

Trump’s Plan To Cheat History
China has slashed its U.S. Treasury holdings by more than 45% from their peak, while building gold vaults and payment networks that bypass the dollar entirely. Since the Federal Reserve opened in 1913, the dollar has lost most of its purchasing power. Porter Stansberry argues a new monetary order is forming around AI infrastructure, chips and energy, pointing to stocks like Vertiv, GE Vernova and Arista Networks that have surged hundreds of percent in recent years.tc pixel
LifeStance Health Group Inc.
What’s Going On With LifeStance Health Group (LFST)?
See More Headlines

LFST Stock Analysis - Frequently Asked Questions

LifeStance Health Group's stock was trading at $7.04 at the beginning of the year. Since then, LFST shares have increased by 83.7% and is now trading at $12.93.

LifeStance Health Group, Inc. (NASDAQ:LFST) issued its earnings results on Thursday, August, 6th. The company reported $0.06 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.03 by $0.03. The business's revenue for the quarter was up 26.1% compared to the same quarter last year.
Read the conference call transcript
.

LifeStance Health Group's Board of Directors authorized a share buyback program on Wednesday, February 25th 2026, which authorizes the company to buy back $100,000,000 in shares, according to EventVestor. This means that the company could reacquire up to 3.6% of its shares through open market purchases. Shares buyback programs are usually an indication that the company's board of directors believes its shares are undervalued.

LifeStance Health Group (LFST) raised $640 million in an initial public offering on Wednesday, June 9th 2021. The company issued 40,000,000 shares at $15.00-$17.00 per share. Morgan Stanley, Goldman Sachs, J.P. Morgan, Jefferies, TPG Capital BD LLC, UBS Investment Bank and William Blair acted as the underwriters for the IPO and Capital One Securities, AmeriVet, Drexel Hamilton, R. Seelaus & Co. and Siebert Williams Shank were co-managers.

LifeStance Health Group's top institutional shareholders include TD Waterhouse Canada Inc. (0.11%), Everhart Financial Group Inc. (0.03%), Yousif Capital Management LLC (0.02%) and Smithbridge Asset Management Inc. DE (0.02%). Insiders that own company stock include Tpg Gp A, Llc, Summit Partners Growth Equity, Summit Partners L P, Darren M Black, Silversmith Partners I Gp, Llc, Kevin Michael Mullins, Eric Shuey, Robert Bessler, Danish J Qureshi, David Bourdon, Ann Varanakis, Lisa K Miller, Paula Cipollone, Vukasin Paunovich and Ujjwal Ramtekkar.
View institutional ownership trends
.

Shares of LFST stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that LifeStance Health Group investors own include Advanced Micro Devices (AMD), SoFi Technologies (SOFI), Micron Technology (MU), NVIDIA (NVDA), PayPal (PYPL), Doximity (DOCS) and ARM (ARM).

Company Calendar

Last Earnings
8/06/2026
Today
10/25/2026
Next Earnings (Estimated)
11/05/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Healthcare Providers & Services
Sub-Industry
Healthcare Services
Current Symbol
NASDAQ:LFST
CIK
1845257
Fax
N/A
Employees
10,961
Year Founded
2017

Price Target and Rating

High Price Target
$18.00
Low Price Target
$8.00
Potential Upside/Downside
+1.5%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.73
Research Coverage
11 Analysts

Profitability

EPS (Trailing Twelve Months)
$0.13
Trailing P/E Ratio
99.47
Forward P/E Ratio
80.81
P/E Growth
N/A
Net Income
$9.66 million
Net Margins
3.19%
Pretax Margin
4.23%
Return on Equity
3.39%
Return on Assets
2.33%

Debt

Debt-to-Equity Ratio
0.18
Current Ratio
1.38
Quick Ratio
1.38

Sales & Book Value

Annual Sales
$1.58 billion
Price / Sales
3.12
Cash Flow
$0.17 per share
Price / Cash Flow
76.87
Book Value
$3.91 per share
Price / Book
3.31

Miscellaneous

Outstanding Shares
382,154,000
Free Float
368,779,000
Market Cap
$4.94 billion
Optionable
Optionable
Beta
1.24

Social Links

The 7 Hottest IPO Stories of 2026 Cover

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report

This page (NASDAQ:LFST) was last updated on 10/23/2026 by MarketBeat.com Staff.
From Our Partners